Tag: Dell Hancock

Grayson-Jockey Club Approves Funding for EHV-1 and EHM Vaccine Research

The Grayson-Jockey Club Research Foundation recently issued a special call for research proposals to address vaccines for Equid Alphaherpesvirus 1 (EHV-1) and Equine Herpesvirus Myeloencephalopathy (EHM) and after a thorough review process by the foundation's veterinarian advisory committee, two research proposals were selected for funding.

The projects, led by Gisela Soboll Hussey of Michigan State University and Bettina Wagner of Cornell University, aim to develop novel nucleic acid vaccines to protect horses from EHV-1/EHM and EHV-4.

Soboll Hussey's project is titled, “Use of nucleic acid vaccines to protect from EHV-1/EHM,” and it will last three years. Her objective is to develop a novel mRNA-based EHV vaccine that protects horses from EHV-1 myeloencephalopathy, a method that will likely cross-protect horses against other types of equine herpesviruses. Wagner's project, titled, “A novel DNA vaccine platform to control EHV-1 and EHV-4,” will span two years and aims to develop an effective DNA vaccine for EHV-1 to protect horses against infection and disease, working to prevent catastrophic EHV outbreaks in the future.

The EHV-1 and EHM viruses affect horses of every breed and discipline, and they continue to cause significant economic losses through closures of racetracks and sales barns, delays in training schedules, and severe disease and death of horses. Total funding for the projects of $1,885,436 was provided by special donor Dr. John Ballantyne and Fargo-Moorhead Area Foundation.

“The work of our research advisory committee is timely and essential,” Dell Hancock, chairman of the Grayson-Jockey Club Research Foundation, said. “We look forward to working with these institutions to develop these vaccines and protect the equine industry from the devastating effects of EHV-1 and EHM.”

The post Grayson-Jockey Club Approves Funding for EHV-1 and EHM Vaccine Research appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Grayson-Jockey Club Foundation Seeking Applications For EHV Vaccine Research Development

Grayson-Jockey Club Research Foundation has issued a formal call for research applications focused on the development of a nucleic acid-based vaccine against equine herpes virus (EHV). Dr. John Ballantyne and Fargo-Moorhead Area Foundation have committed $2 million to fund this research.

“We are so grateful to Dr. Ballantyne for his generosity in supporting efforts to address EHV, a disease that affects all horses,” said Dell Hancock, chair of the foundation. “This gift will enable Grayson to continue its commitment to funding critical research for horses, and our research advisory committee looks forward to seeing what proposals are submitted.”

“As a horse owner with a biotechnology background, I recognize the danger of EHV and see the potential for nucleic acid-based vaccines for combating this disease,” said Dr. Ballantyne. “I am proud to work with Grayson to support EHV research.”

Grayson is interested in research proposals focused on EHV-1, EHV-3, and EHV-4, with a multivalent or pan-valent approach. Researchers must have the ability to conduct an in vivo proof of principle of efficacy in the equine model in-house or through collaboration. Applications from established equine investigators collaborating with experts from other fields (e.g., human vaccinologists) are strongly encouraged. It is anticipated that this research will span three to four years and possibly multiple projects.

Grant applications are due October 1, 2022, and can be submitted at grayson-jockeyclub.org.

Grayson-Jockey Club Research Foundation is traditionally the nation's leading source of private funding for equine medical research that benefits all breeds of horses. Since 1983, the foundation has provided more than $30.6 million to fund 397 projects at 45 universities in North America and overseas. Additional information about the foundation is available atgrayson-jockeyclub.org.

The post Grayson-Jockey Club Foundation Seeking Applications For EHV Vaccine Research Development appeared first on Horse Racing News | Paulick Report.

Source of original post

Grayson-Jockey Club Research Foundation Establishes ‘A. Gary Lavin Chair’; Oaklawn Park Donates $250,000

Grayson-Jockey Club Research Foundation announced today the creation of an endowment to support a full-time position, the “A. Gary Lavin Chair,” in recognition of Dr. Gary Lavin's contributions to the foundation and equine health. Lavin died at age 83 in February.

“Dr. Lavin made innumerable contributions to Grayson over the last 40 years, including time spent as a valued member of both our board of directors and research advisory committee (RAC),” said Dell Hancock, chair of Grayson. “He was instrumental in the reorganization of our research approval process, which resulted in the development of the research advisory committee we use today. Dr. Lavin believed that the veterinary community should be involved in Grayson's work, and we are proud to honor him with this position, which will facilitate a veterinary relationship with the foundation that he believed was so important.”

[Story Continues Below]

Oaklawn Park will be supporting this new role with a lead gift of $250,000.

“We are grateful to Oaklawn and the Cella family for their demonstrated commitment to equine health in helping to fund this position,” Hancock said.

“For three generations, the Cella-Lavin families have been working together in the best interest of the Thoroughbred,” said Louis Cella, president of Oaklawn. “We all have such great memories of Doc. It is a great honor to kick off this campaign to create the A. Gary Lavin Chair.”

Responsibilities of the A. Gary Lavin Chair will include RAC member recruitment, orientation, and management; management of grant applications, reviews, deadlines, and conflict eliminations; fundraising; and publicity.

“My father was a lifelong advocate of equine health and longtime supporter of Grayson, and my family is proud to see his legacy continue through this new position,” said Kevin Lavin, vice chairman of Grayson. “We are appreciative of the support that it has already received and thankful to the Cella family for their initiative in the fundraising effort.”

Those who are interested in supporting the endowment can designate donations to Grayson as being specifically for the A. Gary Lavin Chair position.

Grayson-Jockey Club Research Foundation is traditionally the nation's leading source of private funding for equine medical research that benefits all breeds of horses. Since 1983, the foundation has provided more than $30.6 million to fund 397 projects at 45 universities in North America and overseas. Additional information about the foundation is available at grayson-jockeyclub.org.

The post Grayson-Jockey Club Research Foundation Establishes ‘A. Gary Lavin Chair’; Oaklawn Park Donates $250,000 appeared first on Horse Racing News | Paulick Report.

Source of original post

Grayson-Jockey Club Creates ‘A. Gary Lavin Chair’ Position

Grayson-Jockey Club Research Foundation announced Monday the creation of an endowment to support a full-time position, the “A. Gary Lavin Chair,” in recognition of Dr. Gary Lavin's contributions to the foundation and equine health. Lavin died at age 83 in February.

“Dr. Lavin made innumerable contributions to Grayson over the last 40 years, including time spent as a valued member of both our board of directors and research advisory committee (RAC),” said Dell Hancock, chair of Grayson. “He was instrumental in the reorganization of our research approval process, which resulted in the development of the research advisory committee we use today. Dr. Lavin believed that the veterinary community should be involved in Grayson's work, and we are proud to honor him with this position, which will facilitate a veterinary relationship with the foundation that he believed was so important.”

Oaklawn Park will be supporting this new role with a lead gift of $250,000.

“We are grateful to Oaklawn and the Cella family for their demonstrated commitment to equine health in helping to fund this position,” Hancock said.

“For three generations, the Cella-Lavin families have been working together in the best interest of the Thoroughbred,” said Louis Cella, president of Oaklawn. “We all have such great memories of Doc. It is a great honor to kick off this campaign to create the A. Gary Lavin Chair.”

Responsibilities of the A. Gary Lavin Chair will include RAC member recruitment, orientation, and management; management of grant applications, reviews, deadlines, and conflict eliminations; fundraising; and publicity.

“My father was a lifelong advocate of equine health and longtime supporter of Grayson, and my family is proud to see his legacy continue through this new position,” said Kevin Lavin, vice chairman of Grayson. “We are appreciative of the support that it has already received and thankful to the Cella family for their initiative in the fundraising effort.”

Those who are interested in supporting the endowment can designate donations to Grayson as being specifically for the A. Gary Lavin Chair position.

Grayson-Jockey Club Research Foundation is traditionally the nation's leading source of private funding for equine medical research that benefits all breeds of horses. Since 1983, the foundation has provided more than $30.6 million to fund 397 projects at 45 universities in North America and overseas. Additional information about the foundation is available at grayson-jockeyclub.org.

The post Grayson-Jockey Club Creates ‘A. Gary Lavin Chair’ Position appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights